OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance
Alexander Rudich, Ramiro Garzon, Adrienne M. Dorrance
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12271-12271
Open Access | Times Cited: 8
Alexander Rudich, Ramiro Garzon, Adrienne M. Dorrance
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12271-12271
Open Access | Times Cited: 8
Showing 8 citing articles:
Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia
Jingnan Sun, Ruiping Hu, Mengyuan Han, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 175-181
Open Access | Times Cited: 12
Jingnan Sun, Ruiping Hu, Mengyuan Han, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 175-181
Open Access | Times Cited: 12
Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 3
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M. A. Altalbawy, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 3
Clinical Validation Of ANKRD36 Mutations As A Novel Biomarker For Monitoring Early Progression and Timely Clinical Interventions In Blast Crisis CML
Nawaf Alanazi, Muhammad Absar, Abdulaziz Siyal, et al.
(2024)
Open Access | Times Cited: 1
Nawaf Alanazi, Muhammad Absar, Abdulaziz Siyal, et al.
(2024)
Open Access | Times Cited: 1
Non‐coding RNAs and their potential exploitation in cancer therapy‐related cardiotoxicity
Riccardo Bernasconi, Gabriela M. Kuster
British Journal of Pharmacology (2024) Vol. 182, Iss. 2, pp. 296-315
Open Access | Times Cited: 1
Riccardo Bernasconi, Gabriela M. Kuster
British Journal of Pharmacology (2024) Vol. 182, Iss. 2, pp. 296-315
Open Access | Times Cited: 1
Preleukemic Fusion Genes Induced via Ionizing Radiation
Pavol Košík, Milan Škorvaga, Igor Belyaev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6580-6580
Open Access | Times Cited: 3
Pavol Košík, Milan Škorvaga, Igor Belyaev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6580-6580
Open Access | Times Cited: 3
Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
Rachid Lahlil, Anne Aries, Maurice Scrofani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16671-16671
Open Access | Times Cited: 2
Rachid Lahlil, Anne Aries, Maurice Scrofani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16671-16671
Open Access | Times Cited: 2
Investigations on Clinical Validation of mutated ANKRD36 as a Novel Molecular Biomarker for Monitoring Early Progression and Timely Therapeutic Interventions in Blast Crisis CML
Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Nawaf Alanazi, Abdulaziz Siyal, Muhammad Absar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML
Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, et al.
(2022), pp. 311-320
Open Access
Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, et al.
(2022), pp. 311-320
Open Access
